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Mutual influences of viruses on the immune system and vice versa
which lead to a biological balance are considered, with clinical
and/or experimental findings. Numbers and turnover of immune
cells can be correlated with numbers and growth rate of viruses;
certain viruses apparently have adapted to systemic or local immune
effector mechanisms. The biological balance of viruses and immune
system guarantees overall protection of both host and parasite. It
also may lead to conditions where immune protective mechanisms
cause cell and tissue damage leading to disease. Immunologically
mediated disease may be influenced by immune regulation via HLA
antigen and may therefore explain HLA-disease associations.
Finally, the different specificities of antibodies vs. T cells and the
differing kinetics of their immunological memory are outlined and
correlated with immune escape, immune protection and the
resulting possible evolutionary pressures on viruses.
Although immunological mechanisms are only one part of a
vertebrate host's defence mechanism, they undoubtedly play an
important role in limiting infectious disease. Immunodeficient
humans or mice usually succumb to infectious disease and not to
tumours or degenerative disease. T cell-deficient patients die from
viral infections, whereas agammaglobulinaemic children survive
many viral infections well but succumb to bacterial infections (for
reviews see refs. 1-5). These experiments of Nature clearly
indicate that the two main parts of the immune system, humoral
and cell-mediated, cover different areas of infectious diseases.
Extracellular parasites (mainly bacteria) are checked immunologi-
cally by antibodies and complement factors, whereas intracellular
parasites (viruses, facultative intracellular bacteria) are controlled
mainly by T cells and cell-mediated immunity.
The host-virus relationship depends on a variety of factors
which lead to a well balanced evolutionary equilibrium between
infectious agents and hosts. Factors influencing viruses include
the degree of cytopathogenicity, organ or cell tropism, susceptibil-
ity to immune modulation, to interferon, or to concurrent
infections; factors determined by the host are the degree of
immunocompetence, immune response regulation, natural resis-
tance factors, genetic factors etc. Some viruses, such as pox and
influenza, are highly cytopathic and therefore threaten the life of
their host much more than non- or poorly cytolytic viruses (such as
human hepatitis B virus, or lymphocytic choriomeningitis virus
(LCMV) in mice). It is obvious that the more destructive for cells a
virus is, the greater is the need for rapid and efficient elimination
by the host. The immune system, as we know it in higher
vertebrates today, must therefore offer otpimal defence (immune
protection) against cytopathic viruses. However, such an efficient
approach may have disadvantages when dealing with non-lytic
viruses; these may cause immunologically mediated damage of
cells and organs, i.e., immunopathology.
Some General Considerations
Virus Infection and Immunity
Viruses infect higher vertebrates via skin, mucous membranes or
enter the blood directly (via insect bites). After replication, virus
reaches local lymph nodes where it replicates further and then
spreads systemically via blood to secondary organs. In the case of
poxvirus infection or measles, these two phases each take about 4-7
days. Replication time, kinetics of induction of viral antigen on
the cell surface, extent of cell destruction caused by the virus etc,
vary from one virus to another. All viruses usually give the
immune system a signal, either on the surface of infected cells or on
antigen-presenting cells (which take up viral antigens produced in
surplus or are themselves infected). Infection with some viruses does
not lead to induction of virus-specific antigens, while, in other cells,
such induction may occur but not be recognized. In these cases,
virus may replicate uninhibited before it is recognized immunolo-
gically, thus giving the virus a disasterous advantage. Usually T
cell-mediated immunity is measurable systemically within 4-6 days
after general spread of virus, at about the time when viral titres
begin to decrease. In contrast, antibodies become detectable only
later, particularly the biologically relevant neutralizing antibodies
which are often first measurable days or weeks after virus has
disappeared. Antiviral antibodies against various structural and
non-structural viral antigens are often detected early, but their
antiviral role is unclear.
Number Games
Infectious agents, particularly viruses, have one advantage over
vertebrate hosts: their number. They usually multiply rapidly (e.g.
viruses, bacteria) and therefore mutations may arise within short
periods of time. Viruses multiply 100 to 10000 times within one
infectious cycle (6-24 hours) and bacteria usually divide every 30-
60 minutes. This is to be compared with the multiplication or
generation times of mice or humans which are orders of magnitude
longer, i.e. 3-5 months or 13-25 years respectively.
From this numbers point of view, lymphocytes are the means to
render this situation more balanced biologically. Lymphocytes
divide every 12-24 hours, and there are some 109 in mice or about
1012 in humans. Their great numbers and rapid replication times
allow for mutational adaptation and therefore give appropriate
flexibility for immune defence against changing infectious agents.
Therefore, one can explain why the immune system is built of
single mobile cells, in great numbers with relatively short half lives
and great proliferative potential; such a system is adequate to
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enable long lived hosts to deal efficiently with the many different
and highly mutating viruses and bacteria.
Immune Geography
Viruses differ with regard to cytopathic effects, tropism,
replication, interferon induction but also with respect to host
range, or the portal of entry into the host. Here we consider two
aspects in particular: first, which cells must be infected so that an
immune response is triggered and second, what is the role of the
entry site of a virus into the host in determining immunologically
mediated recovery from virus infections or prevention of
reinfection.
Experiments with model systems have clearly shown that an
immune response is triggered only if antigen is presented properly
by antigen-presenting cells. Rabies virus may serve as an example:
it may hide in neurons for a considerable length of time before
cytopathic effects destroy cells and viral antigens are set free and
are taken up by antigen-presenting cells.8 Because of these
sometimes rather long incubation periods, early administration of
rabies vaccines circumvents the effective seclusion of rabies virus
in neurons; i.e., inactivated rabies virus is most probably readily
taken up by antigen-presenting cells and this should induce an
immune response. This could explain why postexposure vaccina-
tion works (sometimes) to prevent or ameliorate rabies. In most
other infections, incubation periods are probably too short to make
postexposure vaccination an effective means of accelerating
immune defence.
There is no doubt that induction of T cell-mediated immunity
depends on viral antigen being presented properly to lymphocytes.
In fact, very early after infection most viruses infect tissue
macrophages (Langerhans, Kupffer or dendritic cells) as well as
macrophages in lymph nodes and spleen.8'9 There is no evidence
so far that the T cell response against virus entering via skin or
mucosal surfaces, or entering directly into the blood differs with
respect to specificity, class of T cells (helper, cytotoxic) induced, or
with respect to recirculation patterns of T cells. As will be pointed
out, this contrasts with the distinct immune geography of
antibodies.10 Very little is known about the survival time of
effector T cells and their distribution or recirculation. Cytotoxic T
cell responses fade away extremely rapidly a few days after virus
has been eliminated from the organism ;3-" nevertheless, the
conventional view is that delayed-type hypersensitivity (DTH)
mediated by T cells is long-lived and can be elicited for many
years. 1'2-5>12 However, this notion may be misleading for two
reasons. First, there is some, although still weak, evidence that
antibodies may be involved in DTH13 and second, there are only
few infectious disease models where DTH can be shown in humans
(e.g. in tuberculosis, leprosy, sarcoidosis, etc.) or in mice, and
where there is no reasonable evidence that either infectious agents
and/or their antigens persists for a long time.'2 Such concomitant
immunity exists where established parasites survive in the
presence of an immune response whereas newly spreading or
freshly entering bacteria of the same type arc eliminated
efficiently.12
B cells and antibodies, in contrast to T cells, exhibit a rather
marked linkage to the location within the host: IgA on mucous
membranes, IgE in the gut and the skin, IgG and IgM in the
circulation. Antibody responses usually appear more slowly than
T cell immunity; this is probably due largely to the fact that T
helper cells must first be induced before efficient B cell triggering
occurs.14 Also, in contrast to T cells, antibody responses are long-
lasting and memory persists often for many years.
During a virus infection, T cells are normally triggered rapidly
and decline soon after virus elimination; T cell responses are short-
lived, are not easily recalled (see later) and often seem to show a
somewhat broader specificity than B cell responses.14'15 In the
Listeria monocytogenes model in mice and rats, memory T cells
apparently do not recirculate very efficiently when measured some
weeks after infection.16'17 Thus, memory T cells, if they exist at
all, seem to be sessile17 and therefore probably not very efficient in
preventing reinfections at other locations in the host, except
perhaps when the agent enters the spleen.
Immune Protection Versus Imnnmopathology
The immune system is made to eliminate acute, cytopathic
viruses or intracellular bacteria. In general, it fulfils this task very
well indeed. Once the infectious agents and their antigens are
eliminated, the immune responses fade away quickly. Thus, for
acute infectious agents, one does not have to evoke sophisticated
suppressor cells or cellular circuits to regulate an immune
response.18 Rapid increase in the concentration of foreign antigen
on specialized cells6 (macrophages, antigen presenting cells,
dendritic follicular cells) is stimulus enough to provoke a T cell- or
B cell-mediated immune response; mere elimination of such
antigens is enough to stop it.
However, some viruses—maybe most—are not acute cytopathic
agents; therefore such viruses (or bacteria) are not evolutionarily
selective and infected hosts do survive independent of the immune
response. Such agents may be able to infect immune-deficient
hosts or may survive in any host for a long time without causing
disease or death. Hepatitis B virus infections or leprosy in humans
or LCMV infection in mice may serve as examples. The majority
(> 90%) of infectious people generate a potent immune response,
eliminate infectious agents efficiently and rapidly and therefore
show no or few symptoms. The few patients lacking an effective
immune response completely become virus carriers or carriers of
leprospy bacilli19'29 (hepatitis B virus carriers, polar lepromatous
leprosy patients). In a few percent of infected patients, immune
effector mechanisms cannot quite get rid of infectious agents. The
persistant conflict between immunity and infection results in
immunopathological damage as, for example, in agressive hepati-
tis or tuberculoid leprosy. Whenever foreign antigens persist,
immunopathology develops, be it via T cell-mediated effector
mechanisms, or via antibodies forming immune complexes.21 A
common feature of these particular disease states is that the
infectious agents are of inherently low pathogenicity with a
resulting low mortality rate. Furthermore, the disease may
develop slowly without interfering severely with reproduction.
Immune response regulation,1 i>22'28 among other parameters, may
therefore set the stage for developing disease through immunologi-
cal damage. Because major transplantation antigens influence
immune responsiveness profoundly, disease susceptibility may be
associated with certain HLA antigens.
Modulation of the Immune response to an Infectious Agent by
Concomitant Infections by Other Agents
The disease and the immune responses induced by one infectious
agent may modulate the disease and the immune responses induced
by a subsequent infection with a different agent. A classical
example is the finding that skin reactions to tuberculin disappear
during measles infection.1'5 All researchers doing experiments in
mice know that 'sick' mice may give very weak immune responses
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in vivo or in vitro. Immune-deficient hosts often show an aberrant
immune reaction not only because of lack of certain immunological
effector mechanisms, but because these deficiencies lead to altered
functions of the existing immune apparatus; e.g. thymus-deficient
nude mice (nu/nu) possess macrophages that are much more
activated than those found in normal mice.29 In most examples
studied, an existing infectious disease tends to attenuate a second
concomitant infection. The pathophysiological mechanisms in-
volved are not well known; lymphokines, interferons, activated
macrophages, increased natural killer cell activities etc. may play
important roles.30"32 However, it has become apparent more
recently that infectious agents, particularly viruses, may be
responsible for acquired immunodeficiencies. It is far from clear
how a lymphotropic or lymphocytopathic virus or the concomitant
infection by various viruses together lead to impairment of the
immune system. Nevertheless acquired immune deficiency
syndrome (AIDS) may well be the result of such concurrent
infections rather than of a human T leukemia virus (THLV)
infection alone.33
For all we known, these examples of the negative effect of
viruses on the immune system may be the exceptions rather than
the rule. Understanding the mechanisms underlying these diseases
will elucidate important parameters determining the equilibrium
between infectious agents and immune responses.
Antiviral Immunity and Polymorphism of Major Transplantation
Antigens
The fact that the major histocompatibility gene complex (MHC)
influences immune responsiveness has been known for some
time,22"28 but there is also substantial evidence for important roles
of non-MHC genes in regulating susceptibility to infectious
diseases.1"5 Historically MHC immune-response (Ir) genes have
been studied most extensively with respect to their role in antibody
responses:2428 their regulatory role is antigen-specific, dose
dependent, and MHC haplotype (H-2I region in mice, HLA-D/DR
in humans) -dependent. Although the responsiveness phenotype is
dominant, non-responder T cell-B cell interactions cannot be
rescued. Ir genes probably exert their effect on T helper cells either
at the level of the receptor repertoire or at the level of antigen
presentation. Similar effects have been mapped to H-2I and HLA-
D/DR for T cell responses measured by proliferation or DTH.27
Ir gene-dependent regulation of the generation of cytotoxic
effector T cells operates in responses against chemically modified
cells and minor histocompatibility antigen, as well as against viral
antigens.15 These latter types of Ir genes act antigen-specifically
(to a certain degree), they depend on the MHC haplotype and map
to K or D or HLA-A or B,3 4 1 5 i.e., to the same MHC regions that
code for the restricting self-histocompatibility antigen (self-H) of
cytotoxic T cells. Again, non-responsiveness linked to a non-
responder H-2 K or D or HLA-A or B cell cannot be rescued and
has a dominant character.15
Thus, MHC-linked Ir genes that regulate responsiveness of T
cells and the genes coding for the restricting self-H determinant are
apparently identical. This conclusion is strengthened by the
finding that T cell specificity for self is selected in the thymus and
by the thymic MHC, as is the Ir-phenotype of maturing T cells.15
Therefore, selection of the specificity for thymic self-H also
automatically determines the Ir phenotype. In summary Ir-gene
phenomena are a direct consequence of T cells being MHC-
restricted.
Why MHC Polymorphism?
The extreme polymorphism of MHC products has been
explained in many different ways. Most hypotheses assume that
the interest of viruses in K, D products of H-2 or A, B of HLA may
stem from the fact that the latter have evolved from cell and organ
growth-regulating differentiation antigens. The theories differ
mainly in that some imply immunologic reasons for polymorphism
and others do not.22"2*'35 Arguments that polymorphism is not
related to immunity are that polymorphism may serve as a marker
system of individuality that prevents mutual fusion or parasitism
between members of the same or other species. When coupled
with the immune system, polymorphism may prevent the spread of
infectious tumours. Alternatively, polymorphism may have
developed as a pure accident of nature and is maintained only
because relatively closely linked loci are polymorphic (e.g. T/t in
the mouse). A different hypothesis is that, since many viruses
replicate best in multiplying cells, interaction of a virus with cell-
surface antigens involved in cell differentiation and proliferation
may influence susceptibility to infections. None of these mechan-
isms can be disproved, and some may in fact operate in parallel.
As detailed elsewhere in this volume and in preceding sections
here, the most compelling idea is that MHC polymorphism and
MHC-restricted, cell-mediated immunity to intracellular parasites
are intimately linked. Therefore, because T cell effector function
is determined by self-MHC products, the size of the species' T-cell
receptor repertoire for foreign antigens is directly dependent on the
polymorphism of the MHC products.15-2 28-35
Mice infected with the enveloped viruses tested so far generate
strong cytotoxic T cell responses. If this immune activity is
separated into an H-2K and H-2D-restricted response, and one
tests T cell activity against self-K plus virus and against self-D plus
virus separately, great differences are detected. For example, Kk is
associated with very high response to a poxvirus but rather weak
response to lymphocytic choriomeningitis virus. In contrast, D1 is
associated with high response to LCMV, but no measurable
response to the poxvirus. Similar examples may be found for
HLA-A,B restricted T cell function in human23 or for HLA-DR or
H-2I restricted T cells.27
Although the following discussion deals mainly with expression
of virus-specific cytotoxic T cells, it is understood that I-restricted
T cell responsiveness parallels the following example: cytotoxic T
cells are essential for survival and if mice possessed only one single
self-H marker as a receptor for lytic signals delivered by specific T
cells, for example Dk, the consequences would be disastrous for the
species' survival. The first poxvirus pandemic would eliminate all
mice. Polymorphism of self-H alone would reduce this chance
substantially, but not eliminate it entirely, since deaths would
accumulate as one after another of many possible highly mutating
viruses attack. Only duplication of self-H together with polymor-
phism deal effectively with the problem. It would be difficult for
any virus to mutate in such a way as to mimic two or four self-H
markers at the same time or otherwise escape MHC-restricted
immune surveillance.35
This concept implies that MHC products functioning as we
know them today in T cell-mediated immunity, fulfilled other,
related functions earlier during phylogeny. In fact, duplication of
these original MHC loci may have allowed some of them to be
sequestered fucntionally to co-evolve with T cell immunity and
become highly polymorphic. Others may have remained with
original functions as markers for cell interactions, cell differenti-
ation, organ formation, etc. Some of the many MHC-linked 77,
Qa, etc. loci may well represent such examples.
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In essence, we believe MHC polymorphism has developed under
selective pressure by intracellular parasites. This conclusion is
based on the fact that MHC-coded self-H defines the effector
function of T cells, influencing T cell immune responsiveness
because T cells are MHC-restricted.
MHC-Associated Diseases are Mediated by Immimopatbological
Processes Exerted by MHC-Restrkted T Cells: A Speculation
Associations between MHC and disease are not found for acute
infectious diseases but for chronic diseases with an aura of
'autoaggressiveness'.3615 T cell-mediated immunity is intimately
tied to MHC products as outlined in the preceding section.
Recovery from infectious diseases caused by viruses can be
viewed as resulting from the balance between the viruses' ability to
destroy cells (cytopathic effect) and the T cells' ability to kill cells
and destroy tissue (cytotoxicity and/or recruitment of inflamma-
tory cells) to prevent further virus replication. Lymphocytic
choriomcningitis in the mouse19 and aggressive hepatitis or
tuberculoid leprosy20 in humans may serve as examples. This
balance is obviously influenced on one hand by the infectious
agent's cytopathogenicity, tropism, rapidity of spread, generation
time, and susceptibility to other factors such as antibody-mediated
modulation, and on the other hand by the host's degree of
immunocompetence and MHC-linked Ir gene-dependent immune
responsiveness.1"5'15
The response to the highly cytopathic viruses that most
commonly afflict young individuals who are too young to
reproduce either leads to elimination of the virus or to death of the
host. Therefore, life-threatening infectious intracellular agents to
which a population is exposed normally will eliminate low
responders. Survivors will consist only of phenotypic high
responders, and no association between MHC and susceptibility to
disease are noticeable. The finding that all mice are high
responders to pox viruses, LCMV, or parainfluenza virus, three of
the most prevalent infectious agent of the species, fits this concept
very well indeed.
It appears as if MHC-associated diseases are generally found
only in relation to noncytopathic or poorly cytopathic agents that
cause chronic infections and do not usually interfere with
reproduction. Only these types of infections leave a certain leeway
for the balance between immunoprotection versus the damage that
is caused either by the infectious agents or, more importantly, by
the ensuing immune response. From this point of view, we would
consider MHC-associated diseases to be immunopathologically
mediated diseases and vice versa.15
The association between susceptibility to disease and the MHC
may develop depending again on the viruses' characteristics, its
susceptibility to immune modulation, and the host's immunocom-
petence at the time of contact as follows, (a) MHC-linked low
responsiveness to a poorly cytopathogenic virus may magnify the
spread of virus and the subsequent extensive and chronic cell-
mediated destruction of host tissue. Here, low-responder MHC
alleles are associated with increased susceptibility when compared
with high responder MHC alleles. (b) MHC-linked low responsive-
ness to a poorly cytopathogenic virus that has already spread
widely (under the cover of prenatal immunoincompetence, for
example, or because of temporary immune modulation by passive
maternal immunity or concurrent infection with other agents) may
be associated with decreased susceptibility to disease. The latter
example would fit the fact that many MHC disease associations are
dominant.
An important characteristic of the association between MHC
type and susceptibility to disease is that it involves the entire
haplotype configuration rather than single MHC alleles. Perhaps
this may be explained by the following proposal: since MHC-
restricted T cell activities are interconnected, certain combinations
of HLA-A plus HLA-D or HLA-B plus various HLA-D region
alleles may influence the overall result of immune responsiveness;
e.g. HLA-D-restricted interactions between T helper cells and
other lymphocytes or between T cells and macrophages may
ultimately generate HLA-A,B-restricted cytotoxic T cells. Alter-
natively, the inaccuracy of serological MHC typing may render
associations more loose than they actually are. Either mechanism
may cause linkage with haplotype rather than single loci.
MHC disease association reflects involvement of MHC-
restricted T cells in the disease process. What are the conse-
quences of such a proposal? As mentioned above, immunopatho-
logy may result from various pathophysiological mechanisms.
Therefore, only some individuals may profit from immunosuppres-
sive therapy, although at this time no guidelines are at hand.
The above speculation suggests careful examination of the use of
attenuated live vaccines. Such vaccines may shift the balance of
the immune response from immune protection towards immuno-
pathological damage. On the other hand, if an infectious agent
causes immunopathological disease, an appropriate vaccine should
induce efficient elimination of this agent before widespread
immunopathologic damage is done. Ultimately, to understand
immunopathological disease and its linkage to MHC and to devise
treatment, we must have at hand a comprehensive biochemical
analysis of T cell receptors and of the recognized foreign (viral,
bacterial) and self determinants. Furthermore we must have a
refined knowledge of viral physiology and of the interaction
between virus and vertebrate host.
T Cell Ys. B Cell Specificity Against Viruses
The two major pathways of antiviral immunity are cellular and
humoral immunity. Cellular immunity is represented mainly by T
cells that act locally via contact on a one-to-one cell basis in solid
tissue. The humoral immune system is composed mainly of B cells,
whose induction depends on T helper cells. The biologically active
products of B cells, 'antibodies', multiply the effector units of one B
cell more than 10000 times in concentration independent (IgM)or
dependent forms (IgG, IgA, IgE). Both T cells and antibodies
have in common that uniform and stereotyped mechanisms are
focused on to the site where foreign antigen is present. Whereas T
cells recognize antigen only when associated with cell surfaces, B
cells recognize both cellular and soluble antigens. Induction and
triggering of effector mechanisms of T cells is mediated via their
specificity for self-MHC products. Antibody effector function is
mediated via the Fc portion, which binds either to Fc receptors
(e.g. IgE on mast cells or basophils) or binds Clq, initiating the
complement cascade. Therefore, effector functions triggered via T
cell or antibody recognition are similar; both link specificity for
foreign antigenic determinants with stereotypic receptors for
mediating effector functions. The fact that at least some of the
complement components map within the MHC, as do the
restriction elements for T cells, is an interesting finding that has
evoked speculation, but so far no definite explanations.
A major problem for the purely analytical approach to
immunology is that immunological specificity is relative. Speci-
ficity of antibodies can be defined adequately by association
constants. Although an antibody anti-A may bind to A only 100 to
1000 times better than to B, there is usually no dispute that this
antibody (particularly in concert with the rest of the complex anti-
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A immune response) is specific against A. Since we cannot
measure T cell receptor binding quantitatively to any comparable
extent, we must be very careful not to overinterpret experimental
results with T cells obtained usually on a simple +/— scale.
Besides evidence that T cells may recognize similar or identical
antigenic determinants14 (particularly on small proteins used often
in experimental immunology) to those seen by B cells, there is also
data which suggests that T cells recognize different parts of
biologically relevant (e.g. viral) antigens than do B cell.37^10 The
reasons for these differences are still debated and unclear but one
way of resolving them would be to show that there were T cell
clones that recognize the same determinants on viral haemagglu-
tinins as do B cells. There is evidence, however that cross-reacting
T cell precursors predominate in primary immune responses.37"39
To argue that T cells possess a different receptor repertoire and
different receptors from B cells is unfounded at the moment, since
we have no direct evidence for or against such speculations.
Most likely, however, differing specificities of T and B cells may
reflect topographical characteristics of antigens on cell surfaces,
where virally induced antigens usually trigger immune responses.
Because T cells recognize antigen-X together with self-MHC
products, both X and self-MHC must be fairly close on the cell
surface, irrespective of which T cell receptor model (1 or 2 receptor
site(s)) is valid. If determinant X is much more distal from (or too
proximal to) the cell surface compared to the relevant self-MHC-
determinant, X will not induce a proper response. Since B cells
recognize X independently of self-MHC they may preferentially
recognize peripheral determinants on cell surface because of their
easy accessibility. Theoretical calculations have been made to
evaluate access of antibody to determinants on influenza virus
haemagglutinins. The results suggest that antibody may interact
with distal (more variable) determinants but not with the
(constant) proximal ones of haemagglutinins mainly because of
simple space restrictions.41 Therefore, one may speculate that the
relative topography of viral determinants on both infected cells and
on virus particles may directly determine T vs. B immune
responses and specificity. Vice versa, the antigenic structure and
topography of relevant viral antigens may be moulded by the
immune system so as to permit survival of both viruses and
vertebrate hosts,39"41 an example of which is given in the following
section.
A special case is the interdependence of the variation of
influenza virus haemagglutinins and neutralizing antibodies
produced in the population. Epidemiological and serological
evidence in vivo and more recently experiments in vitro suggest
that the changing patterns of influenza virus infections are the
results of pre-existing antibodies guiding evolution of new
influenza virus strains. Elegant reviews have been written and
interesting speculations have been presented to explain why
influenza viruses change within a serological subtype (e.g. H3)
several times by antigenic drift before new haemagglutinin
subtypes (e.g. H2) appear epidemiologically, a phenomenon called
antigenic shift.39 Whereas the former phenomenon is most often
caused by mutations, the latter process is due to reassortment of
various influenza gene segments of differing origins. Antibodies
pre-existing in the population thus influence the selection and the
success of one or other new viral haemagglutinins.
T Versos B Cell Memory
The high degree of non-cross-reactivity of neutralizing antiviral
antibody, compared with frequent cross-reactivity of T cell against
serologically distinct viruses, is probably the result of evolutionary
pressures by the immune system exerted on viruses that depend on
haematogenic spread and/or infection of IgA-releasing mucous
membranes. This conclusion is based on the following findings. T
cells disappear quickly after a primary infection whereas antibo-
dies usually persist at high level; the latter effectively and
immediately neutralize reinfecting identical and newly infecting
serologically cross-reactive viruses. Within given geographic
areas, selection therefore favours serologically non-cross-reactive
viruses.39"41 Conventionally, immunological memory is accepted
to exist at both the B and T cell level.14 The concept of vaccination
depends entirely on the existence of immunological memory.
Nevertheless, it is not quite clear whether B cell memory is kept
alive because of (a) persistence of antigen, (b) continuous exposure
to cross-reactive 'natural' environmental antigen, or (c) existence
of true memory B cells. Evidence for T cell memory has been
summarized in various reviews (e.g. ref. 14). Presumed T cell
memory has been shown with classical experiments on carrier-
specific T cells helping hapten-specific B cells. A common factor
in most of these studies is that T cell memory was studied rather
early, i.e., 3-8 weeks after priming. One therefore may argue that
T cell memory is more a quantitative than a qualitative change, in
that the precursor frequencies of relevant T cells are temporarily
increased but that this persists only for a short period of
time.
What speaks against the existence and/or the biological
relevance of memory T cells? Firstly, T cell responses against
viruses11'15 or facultative intracellular bacteria16'17 are rather
short-lived. Anti-viral cytotoxic T lymphocyte (CTL) responses
usually peak about 2-3 days after virus titres are maximal and are
not measurable beyond 2-4 days after viral titres have fallen below
detection level; the same is true for T cell responses against
facultative intracellular bacteria such as L. monocytogenes. Sec-
ondly if the kinetics of secondary antiviral T cell responses are
compared with primary responses, hardly any of the classical
parameters of immunological memory are noticeable. There is (a)
no appreciable acceleration and (b) no augmentation of the
response (increase of affinity cannot be assessed for T cells). Our
own experiments (unpublished) have shown this clearly for CTL
responses against vaccinia virus, vesicular stomatitis virus and
LCMV in mice. If one examines data from the biased point of
view presented here, the same interpretation is hidden in studies on
T cell responses against arborviruses44 influenza virus37'38 and L.
monocytogenes.l6J1 Thirdly, there is old evidence in the literature
that memory and protection against vaccinia virus, which is
predominantly T cell dependent, is rather short-lived. There is,
however, no doubt that vaccination with vaccinia does protect
against systemic haematogenic spread (as do all vaccinations)
because of triggering of neutralizing antibodies.
Admittedly, the speculation presented here does not explain
satisfactorily one finding of experimental in-vitro immunology.
That is that unprimed lymphocytes camot be triggered to a
measurable antiviral response in vitro, whereas in-vivo primed T
cells readily respond to restimulation in vitro. Whether this is due
to increased relative precursor frequencies alone or because our
culture conditions are still somewhat limiting remains to be
evaluated.
The existing cross-reactive T memory cells are apparently rare
and they need time for amplification before migrating and
functioning at the site of infection. Protection by secondary T cell
responses is speeded up only slightly or not at all as compared to
recovery from primary infections, leaving ample time for virus
replication. Therefore, recovery from primary infections by
viruses (e.g. influenza, reoviruses, VSV, and togaviruses) that are
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(a) related and exist in serologically non-cross-reactive subtypes,
and (b) induce cross-reactive T cells, may well depend on cellular
immunity (T helper and cytotoxic cells) and later also on humoral
immunity. In contrast, protection against reinfection by these
viruses may depend mostly on pre-existing local IgA (e.g. influenza,
VSV) or systemic IgG antibodies (e.g. togaviruses).
Both the differing specificities of antiviral antibody vs. T cell
responses and the differences in B cell memory and persistence of
an antibody responses vs. absence of T cell memory may be
explained by the balanced interrelationship between infectious
agents and veretebrate host. The question why B cell memory
apparently exists in contrast to T cell memory is unanswered but
puzzling. Is it because antibodies and B cells form a circular
system as speculated in the network hypotheses?45-46 Alter-
natively, it is because of the requirement for vertical transmission
of antibodies from mother to offspring, via placenta in utero, via
milk neonatally or via egg yolk in chickens to provide early
protection during ontogeny? In contrast, T cells are the
physiologically older part of the immune system, which cannot be
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